🇺🇸 FDA
Pipeline program

TRT

PROLONG-3

Unknown other active

Quick answer

TRT for Prostate Cancer is a Unknown program (other) at First Tracks Biotherapeutics with 1 ClinicalTrials.gov record(s).

Program details

Company
First Tracks Biotherapeutics
Indication
Prostate Cancer
Phase
Unknown
Modality
other
Status
active

Clinical trials